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Abstract
Background: Nosocomial infections are a major threat to patients in the intensive care unit (ICU). Limited data
exist on the epidemiology of ICU-acquired infections in China. This retrospective study was carried out to
determine the current status of nosocomial infection in China.
Methods: A retrospective review of nococomial infections in the ICU of a tertiary hospital in East China between
2003 and 2007 was performed. Nosocomial infections were defined according to the definitions of Centers for
Disease Control and Prevention. The overall patient nosocomial infection rate, the incidence density rate of
nosocomial infections, the excess length of stay, and distribution of nosocomial infection sites were determined.
Then, pathogen and antimicrobial susceptibility profiles were further investigated.
Results: Among 1980 patients admitted over the period of time, the overall patient nosocomial infection rate
was 26.8% or 51.0 per 1000 patient days., Lower respiratory tract infections (LRTI) accounted for most of the
infections (68.4%), followed by urinary tract infections (UTI, 15.9%), bloodstream (BSI, 5.9%), and gastrointestinal
tract (GI, 2.5%) infections. There was no significant change in LRTI, UTI and BSI infection rates during the 5 years.
However, GI rate was significantly decreased from 5.5% in 2003 to 0.4% in 2007. In addition, A. baumannii, C.
albicans and S. epidermidis were the most frequent pathogens isolated in patients with LRTIs, UTIs and BSIs,
respectively. The rates of isolates resistant to commonly used antibiotics ranged from 24.0% to 93.1%.
Conclusion: There was a high and relatively stable rate of nosocomial infections in the ICU of a tertiary hospital
in China through year 2003–2007, with some differences in the distribution of the infection sites, and pathogen
and antibiotic susceptibility profiles from those reported from the Western countries. Guidelines for surveillance
and prevention of nosocomial infections must be implemented in order to reduce the rate.
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Nosocomial infections, also called healthcare acquired
infections or health care-associated infections, is defined
by the CDC as a localized or systemic condition resulting
from an adverse reaction to the presence of an infectious
agent(s) or its toxin(s), without any evidence that the
infection was present or incubating at the time of admis-
sion to the acute care setting [1]. Nosocomial infections
have become an important public health issue worldwide.
Nosocomial infections may result in an excess length of
stay in hospital for up to 10 days and an increase in the
costs of hospitalization.[2,3] Nosocomial infections pose
a critical threat to patients, especially in the high-risk
departments, such as the Intensive Care Unit (ICU).[4,5]
In industrialized countries, nosocomial infections occurs
in 2–12% of hospitalized patients, with the rates being up
to 21% in ICU, while the rates are 3–18% in hospitalized
patients with the rates being up to 54% in ICU. [5-11] In
China, there are more than 10,000 hospitals with signifi-
cant differences among each other in the size, facilities,
administration, teaching, research and academic levels. A
few studies reported nosocomial infections in China, but
these studies were limited in small sample sizes and short
period of time, publication in Chinese journals, with or
without English abstracts. [11-13] Recently, we carried out
a retrospective study to determine the current status of
nosocomial infections in a tertiary hospital in East China.
All data on nosocomial infections between year 2003 and
2007 were retrieved and reviewed. The overall patient
nosocomial infection rate, the incidence density rate of
nosocomial infections, the excess length of stay, and dis-
tribution of nosocomial infection sites were determined.
Then, pathogen and antimicrobial susceptibility profiles
were further investigated.
Methods
The study was performed in the Affiliated Hospital of
Wenzhou Medical University, which situates in Zhejiang
province, East China, with over 1000 beds and one mixed
ICU of 13 beds. Since 1996, the hospital started an infec-
tion control program, including collection of data on
infections acquired in the hospital. In the present study,
data from January 2003 to December 2007 for patients in
the ICU were retrieved by the Infection Control Team
since completed raw data of the patients in ICU were
available only after 2003. This retrospective study was
approved by the Medical Ethics Committee of The Third
Affiliated Hospital, Wenzhou Medical College.
All patients admitted to the ICU for more than 48 hours
were monitored for nosocomial infections, which were
defined according to the American CDC.[1] Infections
developed within 48 hours of discharge from the ICU
were also considered to be ICU-acquired unless there was
an identified cause after discharge.
The major nosocomial infections, including lower respira-
tory tract infections (LRTIs), urine tract infections (UTIs),
bloodstream infections (BSIs) and gastrointestinal tract
infections (GIs) were defined as followings. LRTIs refer to
lower respiratory tract infection, other than pneumonia,
i.e. bronchitis, tracheobronchitis, bronchiolitis, tracheitis,
without evidence of pneumonia. BSIs refers to laboratory-
confirmed bloodstream infections, UTIs refers to sympto-
matic urinary tract infections and GIs refers to gastrointes-
tinal tract (esophagus, stomach, small and large bowel,
and rectum) infections excluding gastroenteritis and
appendicitis. The detailed criteria to diagnose these noso-
comial infections were described in the CDC documents
[1].
Data on the date and site of infection, patient demo-
graphic information and device use were collected for
each infection. Moreover, data on the isolated pathogens
and their susceptibility testing to antimicrobial agents, if
available, were also collected.
The overall patient nosocomial infection rate was calcu-
lated by dividing the total number of patients with noso-
comial infections by the total number of patients in the
ICU (×100) during the defined period of time (i.e. each
year). The incidence density rate of nosocomial infections
was calculated by dividing the total number of nosoco-
mial infections by the total patient days (×1000) during
the defined period of time. The total patients days were
calculated by summating the days of each patient in the
ICU. In the meantime, the length of stay, which was
defined as the overall days of a patient spent in the hospi-
tal including the ICU and another department to which
the patient was transferred from ICU after stabilization of
the conditions. The excess length of stay was then calcu-
lated by subtracting the average length of stay for patients
without nosocomial infection from that of patients with
nosocomial infections.
Statistical analyses were performed using SPSS software
version 13.2 (SPSS Inc., Chicago, Ill., USA). Chi-square
test and Spearman's rank-correlation coefficients were
applied where appropriate. For all analyses, a P value of
less than 0.05 was considered statistically significant.
Results
From 2003 to December 2007, medical data of 1980
patients discharged from the hospital ICU were colleted.
The average length of stay was 9.95 days, giving 19700
patient-days. Among these patients, 531 patients acquired
a total of 1005 nosocomial infections, including 125
patients with two infections, 33 patients with three infec-
tions, 12 patients with four infections and one patient
with five infections (Table 1).Page 2 of 6
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ranging from 22.6% to 33.2% among the 5 years. There
was a significant difference in the infection rates among
the 5 years (χ2 = 10.395, P = 0.035). The incidence density
rate of nosocomial infections was 51.0 per 1000 patient
days, ranging from 38.5 to 59.2 among the 5 years. The
excess length of stay was 9.4 days, ranging from 3.3 days
in 2003 to 11.5 days in 2004 [see Additional file 1].
Lower respiratory tract infections (LRTIs) including bron-
chitis, tracheobronchitis and pneumonia, were the most
common infections, occurring in 34.7% of the 1980
patients, followed by urine tract infections (UTIs) (8.1%),
and bloodstream infections (BSIs) (3.0%). Among the
1005 nosocomial infections, LRTIs accounted for 68.4%,
followed by UTIs (15.9%), BSIs (5.9%) and gastrointesti-
nal tract infections (2.5%). Most (76.0%) patients with
nosocomial LRTIs had received mechanical ventilation or
tracheotomy before the infections, whereas 50.0% of
nosocomial UTIs and 54.2% of nosocomial BSI were cath-
eter associated (Table 1).
There is no significant change in LRTI, UTI and BSI rates
during the 5 years. The GI infection rate was significantly
decreased from 5.5% in 2003 to 0.4% in 2007 (χ2 =
12.603, P = 0.012), whereas nosocomial infections in
other sites was increased significantly (χ2 = 12.858, P =
0.012). The nosocomial infection rates at the surgical sites
and skin and soft tissues remained under 2% (Table 1).
Pathogens were isolated and identified from 530 (52.7%)
of 1005 nosocomial infections, or, in 338 (63.7%) of the
531 patients. The isolated pathogens responsible for
nosocomial infections differed among the infection sites
(Table 2). In patients with LRTIs, Acinetobacter baumannii
and Klebsiella pneumoniae were the most frequently iso-
lated pathogens, followed by Pseudomonas aeruginosa and
Staphylococcus aureus, accounting for more than half of the
LRTI related pathogen population. In patients with UTIs,
the fungi, especially Candida albicans, were the most com-
mon pathogens, followed by Escherichia coli. Staphylococ-
cus epidermidis, E. coli, and S. aureus were the first three
most common pathogens for BSIs. In addition, A. bau-
mannii was commonly isolated in UTIs and BSIs (Table 2).
Data on susceptibility testing were available for 3328 iso-
lates, including 195 isolates of E. coli, 359 isolates of S.
aureus, and 549 isolates of P. aeruginosa. Overall, 79.3%,
80.0%, 82.3% and 77.8% of E. coli isolates were resistant
to trimethoprim/sulfamethoxazole (TMP/SMX) and cip-
rofloxacin, cefotaxime, and amoxicillin/clavulanic acid,
respectively. All S. aureus isolates were sensitive to vanco-
mycin, but 24.0%, 37.9%, 68.1% and 89.6% of isolates
were resistant to nitrofurantoin, TMP/SMX, rifampin and
ciprofloxacin, respectively. In addition, 93.1%, 41.3%
and 66.9% of P. aeruginosa were resistant to TMP/SMX,
ciprofloxacin and levofloxacin, respectively [see Addi-
tional file 2].
All patients with nosocomial infections were treated with
empirical antimicrobial therapies or according to the anti-
microbial susceptibility test results, when available. The
Table 1: Distribution of nosocomial infections by site
Infection site Number (%) of nosocomial infections during the 5 years
2003 2004 2005 2006 2007
LRTIs 102 (70.3) 121 (71.6) 160 (67.8) 159 (69.4) 145 (64.2)
UTIs 24 (16.6) 28 (16.6) 40 (16.9) 25 (11.2) 43 (19.0)
BSIs 6 (4.1) 4 (2.4) 18 (7.6) 19 (8.3) 12 (5.3)
GIs 8 (5.5) 7 (4.1) 6 (2.6) 3 (1.3) 1 (0.4)
Surgical sites 1 (0.7) 1 (0.6) 2 (0.8) 4 (1.7) 2 (0.9)
Skin & soft tissue 2 (1.4) 2 (1.2) 1 (0.4) 1 (0.4) 3 (1.3)
Other sites 2 (1.4) 6 (3.5) 9 (3.9) 18 (7.7) 20 (8.9)
Total 145 (100) 169 (100) 236 (100) 229 (100) 226 (100)
BSIs, bloodstream infections; LRTIs, lower respiratory infections; UTIs, urinary tract infections; GIs, gastrointestinal infections.
Table 2: Pathogens identified from patients with three major 







A. baumannii 18.9 3.6 9.5
K. pneurnoniae 15.0 3.6 4.8
P. aeruginosa 11.3 1.2 9.5
S. aureus 11.0 0 14.3
C. albicans 9.1 33.3 2.3
S. epidermidis 5.9 3.6 19.0
E. coli 4.0 16.7 16.7
B. cepacia 4.0 0 2.3
Other candida 1.1 21.4 4.8
BSIs, bloodstream infections; LRTIs, lower respiratory infections; 
UTIs, urinary tract infections; GIs, gastrointestinal infections.
n, number of infections in which pathogens were isolated; %, the 
percentage of the pathogens in each of the three infections.Page 3 of 6
(page number not for citation purposes)
BMC Infectious Diseases 2009, 9:115 http://www.biomedcentral.com/1471-2334/9/115mortality rates in the patients with nosocomial infections
were 20.2% (17/84), 12.2% (12/98), 15.1% (18/119),
15.1% (18/119) and 17.1% (19/111), respectively, in
2003, 2004, 2005, 2006 and 2007. However, based on the
medical records, none of the mortalities were directly
related to nosocomial infections.
Discussion
In the present study, the overall patient nosocomial infec-
tion rate in the ICU was 26.8% during 2003 and 2007,
which was higher than in the ICUs in many industrialized
countries where the rates ranging from 7.7% to 16.5%,
[14-16] and even higher than the rate (14.7%) observed
in 55 ICUs of developing countries.[17] However, the rate
is comparable with those reported in some Latin Ameri-
can countries such as Argentina and Brazil [10], and
slightly lower than that reported in India. [18]
Over the 5 years, the lowest rate was reported in 2003
(22.6%), and the highest was reported in 2004 (33.2%).
One plausible explanation is that in the early of 2003 the
country was suffering from the outbreak of highly infec-
tious pneumonia, namely severe acute respiratory syn-
drome (SARS). Due to the massive campaign to prevent
the spread of SARS, nosocomial infections were indirectly
reduced. Being fatigued from the campaign over the previ-
ous year, disinfection and sterilization procedures might
be loosen in 2004, explaining the moderate rebound in
2004. However, the incidence density rate of nosocomial
infections was the lowest in 2004, due to considerably
longer stay of some patients in the ICU (Table 1).
The average length of stay in the hospital varied from 3.3
to 11.5 between 2003 and 2007, with the overall average
being 9.4 days, which is generally in agreement with those
(4.3–15.6 days) reported in European and the United
States [19-21], but much less than that reported in Taiwan
[22]. However, the it must be also mentioned that SARS
outbreak had some impact on the overall length of stay.
Although the average stay in the ICU was only 6.6 days,
the shortest among the 5 years, the average stay in the hos-
pital was the longest for both patients with and those
without nosocomial infections due to the isolation policy
imposed in the special period of time.
The distribution of nosocomial infections in the present
study differed from that reported in the United States. We
found that the LRTIs were the most common infections in
the ICU, accounting for 68.4% of overall infections,
whereas UTIs was the most frequently reported infections
in the ICUs in the United States, with the rate of 31%, fol-
lowed by pneumonia of 27%. [14] The proportions of
UTIs and BSIs in the present study were relatively lower
than the data reported in the United States (15.9% vs.
31% and 5.9% vs. 19%, respectively).[14] Although data
from Europe revealed same three most common infection
sites as the present study did, the absolute proportion of
LRTIs was 47%, [6] which was lower than the rate in the
present study. The common reasons proposed by studies
in many Western countries have suggested that nosoco-
mial LRTIs are mainly due to mechanical ventila-
tion.[5,14] In China, air pollution, high density of
population, and improper health habits such as smoking
may also account for the high rate of LRTIs.
The rate of LRTIs slightly, but insignificantly, decreased
from 2003 to 2007. There was no change in UTIs and BSIs
rates during the 5 years. Notably, the GI rate significantly
and stably decreased every year, suggesting an improve-
ment in the environment and food sanitary in the region.
Since the lower respiratory tract and the urinary tract were
the first two sites that nosocomial infections frequently
occurred in the ICU, constituting more than 80% of all
nosocomial infections in 2003 and 2004, more efforts
were later made to control these two kinds of infections,
leading to decreased rates of lower respiratory tract and
the urinary tract infections, and correspondingly
increased rates of nosocomial infections at other sites.
The present study showed three quarters of LRTI patients
received mechanical ventilation or tracheotomy, more
than half of nosocomial UTI and BSI cases were catheter
associated. These findings are consistent with previous
studies, [4,9,10,14,23] and indicate that the nosocomial
infections are often associated with the use of invasive
device. Therefore, to effectively reduce nosocomial infec-
tions, the use of invasive device should be minimized and
specific disinfection precautions taken during the device
application.
In the present study, pathogens were isolated from 52.7%
of overall nosocomial infections or 63.7% of all patients
with nosocomial infections. Similar to the US report,
Gram-negative bacteria accounted for 53.2% of the LRTIs
in the present study, but the most frequently pathogens
were A. baumannii and K. pneurnoniae in the present study
whereas P. aeruginosa and S. aureus were the most com-
mon pathogens in the US report.[14] Consistent with the
US report, fungi was the most frequently pathogen for
nosocomial UTIs; Candida accounted for 54.7% of UTIs in
the present study, suggesting a relatively narrow profile of
pathogens in nosocomial UTIs. S. epidermidis was the
most common pathogen for BSIs in both the present
study and the US report; however, E. coli, instead of ente-
rococci, was the second common pathogen in the present
study. [14]
E. coli was the most common bacterial cause of nosoco-
mial UTIs, and also frequently found in BSIs and LRTIs. It
has been shown that the activity of beta-lactam antibioticsPage 4 of 6
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mase production, but is restored by the addition of clavu-
lanic acid.[24] In the present study, only 22.2% of E. coli
isolates were sensitive to the formula amoxicillin com-
bined with clavulanic acid, while 78.8% of E. coli isolates
exhibited susceptibility to the combination in an UK
study.[25] A high rate of resistance to TMP/SMX (79.3%)
was observed in these E. coli isolates, in contrast to the rate
of 40% reported in UK [26]. In addition, there was a high
proportion (80.0%) of E. coli isolates resistant to cipro-
floxacin, whereas the rate was less than 10% in UK and the
United States.[26,27] These findings indicate that treat-
ment with these antimicrobial agents for nosocomial
infections caused by E. coli in China is likely to result in
clinical failure in a substantial proportion of patients. We
also found that a considerable number of P. aeruginosa
isolates were resistant to fluoroquinolones, from 41.3%
to ciprofloxacin to 66.9% to levofloxacin, which is com-
parable with the fluoroquinolone-resistant rates (49% to
64%) reported for patients in 55 ICUs of eight developing
countries,[9] but much higher than that (30%) reported
in the United States.[28] All S. aureus isolates in the
present study were sensitive to vancomycin, which was
similar to the observation by Tsuji et al in Japan.[29] In
addition, we observed relatively low resistant rates to
nitrofurantoin (24.0%) and TMP/SMX (37.9%), which
renders these antimicrobial agents suitable for empirical
treatment for S. aureus infections.
In China, The Guidelines for Surveillance and Prevention
of Nosocomial Infections was established in 1994, and
modified in 2000.[30,31] However, surveillance systems
and control measures for nosocomial infections described
in the guidelines were not completely implemented and
executed in all hospitals, due to the imbalanced develop-
ment and health care resources within the countries, and
less attention to nosocomial infections in some hospitals.
Therefore, it is believed that the nosocomial infection
rates must be higher in some rural hospitals or even non-
tertiary hospitals. In addition, due to empirical use or
abuse of antibiotics, the proportion of antibiotic resistant
pathogens for nosocomial infections in many lower level
hospitals would also be higher than that reported in the
present study.
It is noticed that although the mortality rates in patients
nosocomial infections were between 15%–20%, there
was no mortality directly caused by nosocomial infec-
tions. The major reasons for this observation would be the
fact that refractory nosocomial infections are relatively
less encountered based on our susceptibility testing,
which showed that most pathogens were sensitive to
many most commonly used antibiotics, indicating that
they can be effectively controlled. Moreover, Zhejiang is
one of richest provinces in China where medical and
healthcare systems are relatively well established and anti-
infectious therapies are not a big problems. Finally, it
should be emphasized that our hospital is an tertiary
infectious hospital with experience, methodologies and
facilities to combat against various infections including
nosocomial infections.
The present study has some limitations, due to the retro-
spective nature. First, data on risk factors, except for the
use of the medical device, that are potentially associated
with nosocomial infections were not available. These fac-
tors may include the primary diseases for admission to the
ICU, patient resting posture (e.g. semirecumbent or
supine body position), continuous prophylactic use of
anti-peptic ulcer drugs, utilization of the alcohol-based
handrubs and oral care, which need to be taken into con-
sideration in the prospective studies. Second, the data on
the identification and isolation of the pathogens and their
susceptibility were available only for half of the nosoco-
mial infections. It would produce more accurate data if
these numbers were increased. Finally, the data on the
clinical consequences were not available for most cases,
making it impossible to compare the clinical outcomes
between patients with and those without nosocomial
infections. However, the present study was able to show
that the length of stay in the hospital was significantly
increased in patients with nosocomial infections, com-
pared with those without the infections.
Conclusion
In conclusion, there was a high and relatively stable rate
of nosocomial infections in the ICU of a tertiary hospital
in China through year 2003–2007, with some differences
in the distribution of the infection sites, and pathogen
and antibiotic susceptibility profiles from those reported
in the Western countries. The Guidelines for Surveillance
and Prevention of Nosocomial Infections must be imple-
mented national wide in order to reduce the rate.
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